EP
PGNX
Elkfork Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-24,174
| Closed | -$152K | – | 1075 |
|
|
2018
Q3 | $152K | Buy |
24,174
+1,734
| +8% | +$10.9K | ﹤0.01% | 897 |
|
|
2018
Q2 | $180K | Hold |
22,440
| – | – | ﹤0.01% | 823 |
|
|
2018
Q1 | $167K | Buy |
22,440
+5,270
| +31% | +$39.2K | ﹤0.01% | 837 |
|
|
2017
Q4 | $102K | Buy |
17,170
+4,352
| +34% | +$25.9K | ﹤0.01% | 931 |
|
|
2017
Q3 | $94K | Buy |
12,818
+3,094
| +32% | +$22.7K | ﹤0.01% | 915 |
|
|
2017
Q2 | $66K | Buy |
9,724
+5,202
| +115% | +$35.3K | ﹤0.01% | 943 |
|
|
2017
Q1 | $43K | Buy |
+4,522
| New | +$43K | ﹤0.01% | 933 |
|